FAILED
首站-论文投稿智能助手
典型文献
From Bench to the Clinic: The Path to Translation of Nanotechnology?Enabled mRNA SARS?CoV?2 Vaccines
文献摘要:
During the last decades, the use of nanotechnology in med icine has effectively been translated to the design of drug delivery sys?tems, nanostructured tissues, diagnostic platforms, and novel nano?materials against several human diseases and infectious pathogens. Nanotechnology-enabled vaccines have been positioned as solutions to mitigate the pandemic outbreak caused by the novel pathogen severe acute respiratory syndrome coronavirus 2. To fast-track the develop?ment of vaccines, unprecedented industrial and academic collabora?tions emerged around the world, resulting in the clinical translation of effective vaccines in less than one year. In this article, we provide an overview of the path to translation from the bench to the clinic of nanotechnology-enabled messenger ribonucleic acid vaccines and examine in detail the types of delivery systems used, their mechanismsof action, obtained results during each phase of their clinical development and their regulatory approval process. We also analyze how nanotechnology is impacting global health and economy during the COVID-19 pandemic and beyond.
文献关键词:
作者姓名:
Diana O.Lopez?Cantu;Xichi Wang;Hector Carrasco?Magallanes;Samson Afewerki;Xingcai Zhang;Joseph V.Bonventre;Guillermo U.Ruiz?Esparza
作者机构:
Division of Engineering in Medicine,Department of Medicine,Brigham and Women's Hospital,Harvard Medical School,Boston,MA 02115,USA;Division of Health Sciences and Technology,Harvard University-Massachusetts Institute of Technology,Boston,MA 02115,USA;Division of Renal Medicine,Department of Medicine,Brigham and Women's Hospital,Harvard Medical School,Boston,MA 02115,USA;Tecnologico de Monterrey,School of Engineering and Sciences,64849 Monterrey,NL,Mexico;Department of Cardiovascular Surgery,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,People's Republic of China;Harvard T.H.Chan School of Public Health,Boston,MA 02115,USA;Tecnologico de Monterrey,School of Medicine and Health Sciences,64849 Monterrey,NL,Mexico;John A.Paulson School of Engineering and Applied Sciences,Harvard University,Cambridge,MA 02138,USA;School of Engineering,Massachusetts Institute of Technology,Cambridge,MA 02139,USA
引用格式:
[1]Diana O.Lopez?Cantu;Xichi Wang;Hector Carrasco?Magallanes;Samson Afewerki;Xingcai Zhang;Joseph V.Bonventre;Guillermo U.Ruiz?Esparza-.From Bench to the Clinic: The Path to Translation of Nanotechnology?Enabled mRNA SARS?CoV?2 Vaccines)[J].纳微快报(英文),2022(03):1-31
A类:
mechanismsof
B类:
From,Bench,Clinic,Path,Translation,Nanotechnology,Enabled,SARS,CoV,Vaccines,During,last,decades,nanotechnology,med,icine,effectively,been,translated,design,drug,delivery,nanostructured,tissues,diagnostic,platforms,novel,materials,against,several,human,diseases,infectious,pathogens,enabled,vaccines,have,positioned,solutions,mitigate,pandemic,outbreak,caused,by,severe,acute,respiratory,syndrome,coronavirus,To,fast,track,unprecedented,industrial,academic,collabora,emerged,around,world,resulting,clinical,translation,less,than,year,In,this,article,we,provide,overview,from,bench,messenger,ribonucleic,acid,examine,detail,types,systems,their,action,obtained,results,during,each,phase,development,regulatory,approval,process,We,also,analyze,how,impacting,global,health,economy,beyond
AB值:
0.653465
相似文献
Development and Validation of a Prognostic Risk Score System for COVID-19 Inpatients:A Multi-Center Retrospective Study in China
Ye Yuan;Chuan Sun;Xiuchuan Tang;Cheng Cheng;Laurent Mombaerts;Maolin Wang;Tao Hu;Chenyu Sun;Yuqi Guo;Xiuting Li;Hui Xu;Tongxin Ren;Yang Xiao;Yaru Xiao;Hongling Zhu;Honghan Wu;Kezhi Li;Churning Chen;Yingxia Liu;Zhichao Liang;Zhiguo Cao;Hai-Tao Zhang;Ioannis Ch.Paschaldis;Quanying Liu;Jorge Goncalves;Qiang Zhong;Li Yan-School of Artificial Intelligence and Automation,Huazhong University of Science and Technology,Wuhan 430074,China;School of Mechanical Science and Engineering,Huazhong University of Science and Technology,Wuhan 430074,China;Luxembourg Centre for Systems Biomedicine,University of Luxembourg,Belval L-4367,Luxembourg;Department of Emergency,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;AMITA Health Saint Joseph Hospital Chicago,Chicago,IL 60657,USA;Department of Anesthesiology,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Huazhong University of Science and Technology-Wuxi Research Institute,Wuxi 214174,China;Division of Cardiology,Department of Internal Medicine,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Institute of Health Informatics,University College London,London NW1 2DA,UK;Department of Biomedical Engineering,Southern University of Science and Technology,Shenzhen 518055,China;Department of Infectious Diseases,Shenzhen Key Laboratory of Pathogenic Microbiology and Immunology,National Clinical Research Center for Infectious Disease,The Third People's Hospital of Shenzhen(Second Hospital Affiliated with the Southern University of Science and Technology),Shenzhen 518055,China;Department of Electrical and Computer Engineering&Division of Systems Engineering&Department of Biomedical Engineering,Boston University,Boston,MA 02215,USA;Department of Plant Sciences,University of Cambridge,Cambridge CB2 1TN,UK
Macroencapsulation Devices for Cell Therapy
Wei Liu;Yanfang Wang;Jinqiang Wang;Olivia L.Lanier;Marissa E.Wechsler;Nicholas A.Peppas;Zhen Gu-Key Laboratory of Advanced Drug Delivery Systems of Zhejiang Province,College of Pharmaceutical Sciences,Zhejiang University,Hangzhou 310058,China;Department of General Surgery,Sir Run Run Shaw Hospital,School of Medicine,Zhejiang University,Hangzhou 310016,China;Department of Biomedical Engineering,The University of Texas at Austin,Austin,TX 78712,USA;Department of Biomedical Engineering and Chemical Engineering,The University of Texas at San Antonio,San Antonio,TX 78249,USA;Division of Molecular Pharmaceutics and Drug Delivery,College of Pharmacy,The University of Texas at Austin,Austin,TX 78712,USA;Zhejiang Laboratory of Systems and Precision Medicine,Zhejiang University Medical Center,Hangzhou 311121,China;MOE Key Laboratory of Macromolecular Synthesis and Functionalization,Department of Polymer Science and Engineering,Zhejiang University,Hangzhou 310027,China
A Vaccine Based on the Receptor-Binding Domain of the Spike Protein Expressed in Glycoengineered Pichia pastoris Targeting SARS-CoV-2 Stimulates Neutralizing and Protective Antibody Responses
Bo Liu;Ying Yin;Yuxiao Liu;Tiantian Wang;Peng Sun;Yangqin Ou;Xin Gong;Xuchen Hou;Jun Zhang;Hongguang Ren;Shiqiang Luo;Qian Ke;Yongming Yao;Junjie Xu;Jun Wu-Department of Microorganism Engineering,Beijing Institute of Biotechnology,Beijing 100071,China;Medical Innovation Research Division&Fourth Medical Center of the Chinese PLA General Hospital,Beijing 100853,China;Department of Neurosurgery,First Medical Center of the Chinese PLA General Hospital,Beijing 100853,China;Shenzhen Taihe Biotechnology Co.Ltd.,Shenzhen 518001,China;Institute of Physical Science and Information Technology,Anhui University,Hefei 230000,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。